About the company
Procaps Group SA, a renowned developer of pharmaceutical and nutraceutical solutions, has established itself as a leading entity within the global healthcare industry. With an unwavering commitment to research, development, and innovation, Procaps Group has become a trusted provider of medicines, hospital supplies, and nutritional supplements. The company's extensive portfolio encompasses a wide range of products, including over-the-counter (OTC) and prescription drugs, catering to various medical needs and therapeutic areas. By focusing on the development of both conventional and specialized medications, Procaps Group ensures that individuals have access to high-quality, effective treatment options. In addition to pharmaceuticals, Procaps Group also specializes in the creation of nutritional supplements that promote overall health and well-being. These supplements are meticulously formulated using advanced scientific techniques and high-quality ingredients, allowing individuals to maintain a balanced diet and improve their overall vitality. By addressing specific nutritional needs, Procaps Group aims to enhance the lives of individuals by providing them with the necessary nutrients for optimal health. Procaps Group's commitment to continuous improvement and cutting-edge technology can be observed through their high-potency clinical solutions. These solutions are designed to meet the specific requirements of healthcare professionals, ensuring accurate dosing and effective treatment outcomes. With a focus on precision and reliability, Procaps Group supports medical professionals in delivering the best possible care to their patients. The company's success and revenue generation are attributed to its various segments, each playing a vital role in contributing to the overall growth and profitability of Procaps Group. One of the notable segments is NextGel, which focuses on the development of innovative drug delivery systems. By employing advanced technologies, NextGel aims to enhance patient adherence and convenience while ensuring optimal therapeutic outcomes. Another significant segment is Procaps Colombia, which serves as the company's flagship operation. This segment has been instrumental in driving revenue growth, harnessing the expertise and capabilities of Procaps Group to meet the evolving healthcare needs of the Colombian market. Procaps Colombia's commitment to quality, reliability, and affordability has garnered the trust and loyalty of healthcare professionals and consumers alike. Furthermore, the CAN segment, short for Centro de Análisis y Negocios, plays a crucial role in the generation of revenue, offering comprehensive analytical services and supporting business strategies within the healthcare industry. CAN's expertise in market research, data analysis, and business intelligence enables Procaps Group to make informed decisions and remain at the forefront of industry trends and developments. In addition, the CASAND segment specializes in the production of hospital supplies, ensuring that healthcare institutions have access to cost-effective, high-quality products necessary for patient care. By delivering a range of medical supplies and devices, CASAND contributes to the overall efficiency and effectiveness of healthcare systems. Lastly, the Diabetrics segment focuses on providing innovative diabetes management solutions, including devices, medications, and support services. By combining advanced technology with personalized care, Diabetrics empowers individuals living with diabetes to lead fulfilling and healthy lives. Procaps Group SA's commitment to excellence, innovation, and customer satisfaction has positioned it as a trusted partner within the global healthcare industry. With its diverse portfolio, dedicated segments, and relentless pursuit of advancements, Procaps Group continues to make significant contributions to the well-being of individuals worldwide.
Website: https://www.procapsgroup.com
Data updated: June 2, 2026
